Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQ9XY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,166
Award facts
- Contract value 100% obligated
- $11,165.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with a ceiling value of $11,165.95. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which is the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at approximately $1 billion through December 2026, which serves as a comprehensive vehicle for pharmaceutical and medical supply support to federal healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems. The company has established itself as a capable supplier through its extensive portfolio of federal contract awards covering a wide range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific award for Ozempic, a diabetes medication, exemplifies the company's role in supporting Defense Health Agency and broader Department of Defense medical supply chain requirements. The delivery order is scheduled for ultimate completion by November 25, 2025.
Quick answers
Who was awarded contract SPE2DR26FQ9XY?
SPE2DR26FQ9XY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FQ9XY worth?
The government has obligated $11,166 on SPE2DR26FQ9XY.
Is contract SPE2DR26FQ9XY an order under another contract?
Yes. SPE2DR26FQ9XY is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FQ9XY competed?
The extent of competition for SPE2DR26FQ9XY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award